Genzyme CEO Henri Termeer - CEO pay report

Henri A. Termeer

Henri A. Termeer - Genzyme

Total Compensation: $14.6 million

Details: Termeer spent part of 2007 convincing investors that, unlike Biogen Idec and MedImmune, Genzyme wasn't a good takeover target. For his efforts, Termeer gained $1.5 million in base salary--a 5 percent increase over 2006--about $2.1 million in bonuses, $10 million in option awards, and $105,773 in other expenses like travel, insurance and 401(k) contributions.

Genzyme News:
Genzyme on buyouts: Thanks but no thanks
Icahn sells Genzyme stock

Genzyme CEO Henri Termeer - CEO pay report

Suggested Articles

What a difference a day makes in biotech.

A report out this week by PwC thinks that biotech could be in for a good year for deals as it sees the momentum from 2019 growing.

A drug developed at Temple restores a mechanism in brain cells that prevents the toxic buildup of the proteins amyloid beta and tau in Alzheimer's.